STOCK TITAN

If You Invested in Langar Global Healthtech ETF (LGHT)

NYSE
Looking for the current price? See the LGHT quote & overview
$1,000 invested 1 Year Ago
$833
-16.7% total -16.9% CAGR
Bought on Jul 21, 2025 at $10.21
$1,000 invested 5 Years Ago
N/A
Trading since 2024-01-10

What $1,000 or $10,000 in LGHT Would Be Worth Today

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since Jan 10, 2024
$1,000 $833 -17% $836 -16%
$10,000 $8,328 -17% $8,358 -16%

Based on real historical closing prices through the latest market close. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for LGHT

$1,000 Investment Over Time

LGHT vs S&P 500

Year-by-Year Returns

LGHT annual performance
Year Start Price End Price Annual Return Cumulative
2024 $10.18 $10.16 -0.1% -0.1%
2025 $10.23 $10.00 -2.3% -1.8%
2026 $9.98 $8.51 -14.8% -16.4%

About Langar Global Healthtech ETF

NYSE

Langar Global HealthTech ETF (NYSE: LGHT) is described as a pure play HealthTech exchange-traded fund created to focus on companies that use technology to address healthcare challenges. According to information about its sponsor, Langar Holdings, the ETF was launched to address what it characterizes as misclassification and underrepresentation of true health technology companies in traditional healthcare and technology indices.

The ETF is associated with Langar Holdings, which emphasizes active management and expert-driven curation rather than passive index tracking. Available information explains that the firm applies strict criteria to identify what it defines as genuine health tech businesses, focusing on companies that derive a majority of their revenue from tech-enabled products or services that address healthcare pain points. This approach is presented as a response to broad market classifications that can group unrelated businesses under healthcare labels.

The strategy behind Langar Global HealthTech ETF is framed around providing targeted exposure to health technology, rather than broad healthcare or general technology sectors. The sponsor highlights the role of artificial intelligence and other technology tools in healthcare, and positions the ETF as a way for investors to access companies involved in these areas through a curated portfolio.

Langar Holdings describes its process as relying on healthcare industry expertise to evaluate potential holdings. The firm notes that it uses an investment committee with experience across areas such as pharmaceuticals, devices, diagnostics, clinical practice, hospital management, and insurance to review companies and determine whether they meet its definition of health tech. This is intended to create a fund that aligns with a specific interpretation of the HealthTech theme.

LGHT trades on the New York Stock Exchange, giving investors a way to gain exposure to this theme through a listed vehicle. The fund is presented as part of a broader effort by Langar Holdings to define and standardize what qualifies as health technology within public markets.

Business focus and investment approach

The available description of Langar Global HealthTech ETF emphasizes an actively managed approach. Instead of tracking a third-party index, the ETF’s sponsor states that it selects and adjusts holdings based on its own research and expert review. This is positioned as a way to respond to what it views as limitations of passive index methodologies that rely heavily on automated classification systems.

The ETF’s focus on companies that use technology to address healthcare needs places it within the broader intersection of healthcare and technology. The sponsor highlights artificial intelligence in healthcare as an important area of growth and frames LGHT as a vehicle designed to concentrate on companies that meet its internal definition of HealthTech.

Role within the HealthTech and ETF landscape

Information about Langar Global HealthTech ETF presents it as the first ETF that its sponsor describes as a pure play HealthTech fund. In this context, “pure play” refers to the sponsor’s stated goal of including only companies that it considers true health technology businesses under its criteria. This positioning is tied to the sponsor’s view that many existing healthcare or technology funds include companies that are not primarily focused on technology-enabled healthcare solutions.

By structuring LGHT around this narrower definition, Langar Holdings aims to distinguish the ETF from broader healthcare or technology products. The fund is described as part of an effort to align public market investment products more closely with how health technology is defined by sector specialists.

How Langar Global HealthTech ETF is curated

According to available information, Langar Holdings uses a process that combines capital markets experience with healthcare domain expertise. The firm notes that it relies on an investment committee with backgrounds across multiple segments of the healthcare ecosystem to examine companies and determine whether they fit its HealthTech definition. This process is presented as a contrast to approaches that depend primarily on automated keyword or sector classifications.

The sponsor emphasizes that it does not rely solely on algorithms to select holdings. Instead, it states that experts review companies to filter out those that may be labeled as healthcare but do not meet its criteria for technology-enabled healthcare businesses. This is intended to support the ETF’s pure play positioning within the HealthTech theme.

Positioning for investors

For investors, Langar Global HealthTech ETF is presented as a thematic ETF focused on HealthTech, with an emphasis on active management and expert evaluation. The fund’s sponsor highlights the growth and adoption of artificial intelligence and other technologies in healthcare as part of the rationale for creating a dedicated ETF around this theme. LGHT is positioned as a way for investors to access a curated selection of companies that the sponsor believes align with its definition of HealthTech.

Because the ETF is actively managed and built around a specific thematic definition, its holdings and internal criteria are determined by Langar Holdings and its investment committee. Investors considering LGHT would typically review the fund’s official documents and disclosures for details on its investment objective, risks, and portfolio construction.

Current Price
$8.51
View full LGHT overview

Frequently Asked Questions

Langar Global Healthtech ETF investment returns

How much would $1,000 invested in Langar Global Healthtech ETF be worth today?

If you invested $1,000 in Langar Global Healthtech ETF (LGHT) 1 years ago on 2025-07-21, your investment would be worth $833 today, representing a -16.7% total return, growing at a compounded rate of -16.9% per year (CAGR).

Has Langar Global Healthtech ETF outperformed the S&P 500?

Comparison data requires at least 10 years of trading history. Use the calculator above to compare LGHT performance over available time periods.

What is Langar Global Healthtech ETF's average annual return?

The compound annual growth rate (CAGR) of LGHT over the past 1 years is -16.9%, growing at a compounded rate each year. Individual years vary significantly — LGHT's best recent year was 2024 (-0.1%) and worst was 2026 (-14.8%).

Your Privacy is Protected

This calculator sends the symbol, date, and amount you enter to our server so we can fetch historical market data and render the result. We do not save those entries as a portfolio or account, but standard web server logs may still record the page request.

Server-Assisted No Saved Calculator Data Historical Market Data

For informational and educational purposes only — not investment advice.